11:08 AM EDT, 10/30/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were moving sharply lower late Wednesday morning, falling 1.02% to 1,369.52 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Grifols ( GRFS ) and 3D printer company Materialise (MTLS), which rose 5.7% and 2.6%, respectively. They were followed by biopharmaceutical company Genfit ( GNFT ) and internet browser company Opera (OPRA), which were up 2.4% and 2.2% respectively.

The decliners from continental Europe were led by internet advertising firm Criteo ( CRTO ) and biopharmaceutical company Cellectis ( CLLS ) , which dropped 19% and 4.8%, respectively. They were followed by telecommunications company VEON (VEON) and tech conglomerate Philips (PHG), which lost 2.6% and 2.5%, respectively.

From the UK and Ireland, the gainers were led by financial services company Barclays ( JJCTF ) and biopharmaceutical company Verona Pharma ( VRNA ) , which increased 2.2% and 2%, respectively. They were followed by biopharmaceutical company Bicycle Therapeutics ( BCYC ) and construction materials suppler CRH (CRH), which advanced 2% and 1.2%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company TC Biopharm ( TCBP ) and biotech firm Autolus Therapeutics ( AUTL ) , which lost 8% and 5.1%, respectively. They were followed by pharmaceutical companies AstraZeneca ( AZN ) and GSK (GSK), which were down 4.1% and 3.4%, respectively.